British pharma company also announces strategic collaboration agreement
News
Novo Nordisk eyes EU approval for once-weekly semaglutide
Danish pharma is seeking approval for drug as a weight management therapy
NHS England invests £10m in network of ‘long COVID’ clinics
Specialist help will be available at 69 sites across the country
PharmaTimes are excited to announce the launch of INTCR 2021
Flying the flag for excellence in global clinical research, the prestigious PharmaTimes International Clinical Researcher of the Year opens its doors for entry.
EUSA Pharma launches phase III COVID-19 study for siltuximab
Study will enrol hospitalised COVID-19 patients with serious viral acute respiratory distress syndrome
International consortium creates ‘open platform’ for COVID-19 drug discovery
Consortium is led by Cambridge Medical Research Council (MRC) researchers
Kite’s CAR T therapy Tecartus authorised in EU for MCL
CHMP backed the CAR T cell therapy for the treatment of mantle cell lymphoma back in October
Valneva starts UK-based early-stage COVID-19 vaccine trial
French biotech will test vaccine candidate on 150 volunteers across four sites
NICE recommends Novartis’ wet AMD drug Beovu
Final appraisal determination recommends anti-VEGF treatment for NHS use
New research reveals impact of childhood type 1 diabetes on mental health
Surveys uncovers findings pre- and post-pandemic
AZ acquires rare disease specialist Alexion
British drugmaker will acquire Alexion for approximately $39bn
Novo Holdings establishes rare bleeding disorder firm Hemab
New company will focus on developing bispecific antibodies for rare bleeding disorders
RDIF confirms Sputnik V COVID vaccine’s efficacy
The Russian Direct Investment Fund has released a new analysis of data obtained 21 days after administering the first dose of the vaccine, showing efficacy of 91.4%
Pandemic has made little positive impact on public’s view of pharma
A new report launched by Takeda has found that just 17% of UK adults surveyed felt their perception of pharma had improved based on the industry’s response to COVID-19
Green light for UK trial of nasal coronavirus vaccine
The trial is expected to begin next month, with first data anticipated in the second quarter of 2021
